Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

BCC can protect heart cells from damage caused by oxidative stress.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

Yeast extract helps treat hair loss and activates stem cells.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.